Cell therapy medicinal product regulatory framework in Europe and its application for MSC based therapy development

Cited by papers we hold 2

• Stem cell-based therapy for human diseases · 2022
  No notice
• Therapeutic Use of Mesenchymal Stromal Cells: The Need for Inclusive Characterization Guidelines to Accommodate All Tissue Sources and Species · 2021
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.